• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有不确定恶性潜能的子宫平滑肌肿瘤:生育和临床结局。

Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.

机构信息

Department of Gynecologic Oncology, Malatya Education and Research Hospital, Malatya, Turkey.

Department of Gynecologic Oncology, School of Medicine, Gazi University, Ankara, Turkey.

出版信息

J Gynecol Oncol. 2019 Jul;30(4):e54. doi: 10.3802/jgo.2019.30.e54. Epub 2019 Feb 4.

DOI:10.3802/jgo.2019.30.e54
PMID:31074239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6543118/
Abstract

OBJECTIVE

In this study, we aimed to evaluate the clinicopathological features, obstetric, and oncological outcomes of patients diagnosed with a uterine smooth muscle tumors of uncertain malignant potential (STUMP).

METHODS

A dual-institutional, database review was carried out to screen patients with STUMP who were treated with upfront surgery between January 2006 and December 2017. Data including age at the time of diagnosis, recurrence rate, disease-free survival, overall survival, and fertility outcomes were retrospectively analyzed.

RESULTS

Fifty-seven patients with STUMPs were included in the study. The median age at the time of diagnosis was 42 (range, 16 to 75) years. The median follow-up was 57 (range, 16 to 125) months. Eight patients (14%) had recurrence during follow-up. Recurrent STUMPs were seen in seven patients and leiomyosarcoma after 14 months in one patient. Seven patients with a recurrent STUMP survived, while the remaining patient died. Recurrence rates were similar for women who underwent myomectomy and those who underwent hysterectomy. The presence of uterine localization of tumor (subserosal intramural-submucosal) statistically significantly affected recurrence rates (odds ratio=5.72; 95% confidence interval=1.349-24.290; p=0.018). Ten of 27 patients who underwent myomectomy for uterine myoma had fertility desire. Seven pregnancies were recorded.

CONCLUSIONS

Our study results suggest that fertility-sparing approaches are feasible in patients with STUMP, although recurrence may be seen.

摘要

目的

本研究旨在评估诊断为具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP)患者的临床病理特征、产科和肿瘤学结局。

方法

对 2006 年 1 月至 2017 年 12 月期间接受 upfront 手术治疗的 STUMP 患者进行了一项双机构的数据库回顾性研究。回顾性分析了包括诊断时年龄、复发率、无病生存率、总生存率和生育结局在内的数据。

结果

本研究共纳入 57 例 STUMP 患者。诊断时的中位年龄为 42 岁(范围为 16 至 75 岁)。中位随访时间为 57 个月(范围为 16 至 125 个月)。8 例(14%)患者在随访期间复发。7 例患者复发 STUMP,1 例患者在 14 个月后复发平滑肌肉瘤。7 例复发 STUMP 患者存活,而其余患者死亡。行子宫肌瘤切除术和子宫切除术的患者复发率相似。肿瘤子宫定位(浆膜下、壁内-黏膜下)的存在显著影响复发率(优势比=5.72;95%置信区间=1.349-24.290;p=0.018)。27 例行子宫肌瘤切除术的患者中有 10 人有生育愿望,记录到 7 例妊娠。

结论

我们的研究结果表明,对于 STUMP 患者,保留生育力的方法是可行的,尽管可能会出现复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/f91cd265cc39/jgo-30-e54-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/29d986d6417c/jgo-30-e54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/f0f20a8973e7/jgo-30-e54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/629bf078ea30/jgo-30-e54-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/5115b30f4ced/jgo-30-e54-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/f91cd265cc39/jgo-30-e54-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/29d986d6417c/jgo-30-e54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/f0f20a8973e7/jgo-30-e54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/629bf078ea30/jgo-30-e54-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/5115b30f4ced/jgo-30-e54-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5793/6543118/f91cd265cc39/jgo-30-e54-g005.jpg

相似文献

1
Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.具有不确定恶性潜能的子宫平滑肌肿瘤:生育和临床结局。
J Gynecol Oncol. 2019 Jul;30(4):e54. doi: 10.3802/jgo.2019.30.e54. Epub 2019 Feb 4.
2
Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: Oncological and obstetrical aspects.两个妇科中心子宫平滑肌肿瘤恶性潜能不确定的临床经验:肿瘤学和产科学方面
Eur J Obstet Gynecol Reprod Biol. 2020 Mar;246:7-13. doi: 10.1016/j.ejogrb.2020.01.002. Epub 2020 Jan 3.
3
Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience.子宫平滑肌肿瘤恶性潜能未定(STUMP)的临床病理评估:单中心经验
J Gynecol Obstet Hum Reprod. 2019 Oct;48(8):637-642. doi: 10.1016/j.jogoh.2019.03.003. Epub 2019 Mar 18.
4
Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis.子宫平滑肌肿瘤恶性潜能未定:一项回顾性分析。
Gynecol Oncol. 2009 Jun;113(3):324-6. doi: 10.1016/j.ygyno.2009.02.020. Epub 2009 Apr 2.
5
Smooth muscle tumors of uncertain malignant potential or atypical leiomyomas: A long-term evaluation of surgical outcomes and clinicopathological features.具有不确定恶性潜能的平滑肌肿瘤或非典型平滑肌瘤:手术结果和临床病理特征的长期评估。
Eur J Obstet Gynecol Reprod Biol. 2024 Oct;301:201-205. doi: 10.1016/j.ejogrb.2024.07.062. Epub 2024 Aug 2.
6
A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution.单机构子宫平滑肌肿瘤恶性潜能未定(STUMP)的临床病理回顾及产科结局
Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:1-5. doi: 10.1016/j.ejogrb.2018.06.003. Epub 2018 Jun 5.
7
Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.子宫平滑肌肿瘤,恶性潜能未定(STUMP):病理学、随访及复发情况
Int J Clin Exp Pathol. 2014 Oct 15;7(11):8136-42. eCollection 2014.
8
Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center.具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP):单中心回顾性研究。
Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:74-79. doi: 10.1016/j.ejogrb.2021.08.010. Epub 2021 Aug 9.
9
Clinical and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single-center retrospective study.子宫平滑肌肿瘤恶性潜能未定的临床及生殖结局:一项单中心回顾性研究
J Int Med Res. 2021 Apr;49(4):3000605211008065. doi: 10.1177/03000605211008065.
10
Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.子宫平滑肌肿瘤恶性潜能未定及子宫内膜间质肉瘤碎切术的影响:病例系列及临床实践建议
J Minim Invasive Gynecol. 2015 May-Jun;22(4):601-6. doi: 10.1016/j.jmig.2015.01.007. Epub 2015 Jan 14.

引用本文的文献

1
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management.恶性潜能不确定的子宫平滑肌肿瘤:接受保留生育功能管理的患者的生殖及临床结局
Hum Reprod Open. 2025 Mar 3;2025(2):hoaf009. doi: 10.1093/hropen/hoaf009. eCollection 2025.
2
Uterine smooth muscle tumors of uncertain malignant potential: a 13-year retrospective study.子宫平滑肌肿瘤,恶性潜能未定:一项13年的回顾性研究。
Front Oncol. 2024 Nov 7;14:1458968. doi: 10.3389/fonc.2024.1458968. eCollection 2024.
3
Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review.

本文引用的文献

1
A clinicopathologic review and obstetric outcome of uterine smooth muscle tumor of uncertain malignant potential (STUMP) in a single institution.单机构子宫平滑肌肿瘤恶性潜能未定(STUMP)的临床病理回顾及产科结局
Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:1-5. doi: 10.1016/j.ejogrb.2018.06.003. Epub 2018 Jun 5.
2
STUMP, a surprise finding in a large fibroid uterus in a 20-year-old woman.残端,一名20岁女性大子宫肌瘤中的意外发现。
Int J Womens Health. 2018 May 7;10:211-214. doi: 10.2147/IJWH.S153838. eCollection 2018.
3
Immunoexpression of progesterone receptor, epithelial growth factor receptor and galectin-3 in uterine smooth muscle tumors.
接受保留生育功能治疗的子宫肉瘤年轻女性的生殖和肿瘤学结局:一项系统评价
Ther Adv Reprod Health. 2024 Sep 23;18:26334941241271563. doi: 10.1177/26334941241271563. eCollection 2024 Jan-Dec.
4
A Case Report of a Uterine Smooth Muscle Tumor of Undetermined Malignant Potential (STUMP): A Diagnostic Dilemma and Management Challenges.一例具有不确定恶性潜能的子宫平滑肌瘤(STUMP)病例报告:诊断困境与管理挑战
Cureus. 2024 Apr 11;16(4):e58067. doi: 10.7759/cureus.58067. eCollection 2024 Apr.
5
Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update.平滑肌肿瘤的恶性潜能未定(STUMP):全面的多学科更新。
Medicina (Kaunas). 2023 Jul 27;59(8):1371. doi: 10.3390/medicina59081371.
6
A Review and Follow-Up of Uterine Smooth Muscle Tumours of Uncertain Malignant Potential (STUMP): A Case Series and Literature Review.具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP)的回顾与随访:病例系列及文献综述
Diseases. 2023 Jul 31;11(3):99. doi: 10.3390/diseases11030099.
7
Uterine smooth muscle tumors with uncertain malignant potential: analysis following fertility-saving procedures.具有不确定恶性潜能的子宫平滑肌肿瘤:保留生育功能手术后的分析。
Int J Gynecol Cancer. 2023 May 1;33(5):701-706. doi: 10.1136/ijgc-2022-004038.
8
Five-Year Retrospective Study of Uterine STUMP and Leiomyosarcoma.子宫残端和平滑肌肉瘤的五年回顾性研究
Clin Pract. 2022 Nov 10;12(6):897-907. doi: 10.3390/clinpract12060094.
9
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.具有不确定恶性潜能的子宫平滑肌肿瘤(STUMP)的临床和组织病理学复发预测因素:三级中心的多中心回顾性队列研究。
Ann Surg Oncol. 2022 Dec;29(13):8302-8314. doi: 10.1245/s10434-022-12353-y. Epub 2022 Aug 17.
10
Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review.子宫肉瘤的保留子宫治疗:肿瘤学问题与生殖结局:一项系统综述
Cancers (Basel). 2021 Nov 19;13(22):5808. doi: 10.3390/cancers13225808.
孕激素受体、上皮生长因子受体和半乳糖凝集素-3在子宫平滑肌肿瘤中的免疫表达
Cell Mol Biol (Noisy-le-grand). 2018 Apr 30;64(5):7-12.
4
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.基因组分析是一种有效的工具,可以避免平滑肌肿瘤的 STUMP 分类:77 例肿瘤的全面阵列基因组杂交分析。
Mod Pathol. 2018 May;31(5):816-828. doi: 10.1038/modpathol.2017.185. Epub 2018 Jan 12.
5
The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the Diagnosis.21 例具有不确定恶性潜能的子宫平滑肌肿瘤的临床病理研究:集中复习可明确诊断。
Int J Gynecol Cancer. 2018 Feb;28(2):233-240. doi: 10.1097/IGC.0000000000001178.
6
Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Clinicopathologic-Sonographic Characteristics, Follow-Up and Recurrence.子宫平滑肌肿瘤恶性潜能未定:临床病理-超声特征、随访及复发情况
World J Oncol. 2017 Jun;8(3):76-80. doi: 10.14740/wjon1031w. Epub 2017 Jun 9.
7
Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.非典型子宫平滑肌瘤:临床与病理特征的回顾性评估
Oncology. 2018;94(1):1-6. doi: 10.1159/000479818. Epub 2017 Sep 5.
8
Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis.基于不同预后的子宫平滑肌肿瘤分类,p16INK4a的差异表达情况如何?一项荟萃分析。
Genet Mol Res. 2017 Mar 22;16(1):gmr-16-01-gmr.16019481. doi: 10.4238/gmr16019481.
9
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.BCL2在具有不确定恶性潜能的子宫平滑肌肿瘤复发中的潜在作用。
Oncol Rep. 2017 Jan;37(1):41-47. doi: 10.3892/or.2016.5274. Epub 2016 Nov 24.
10
Successful pregnancy following myomectomy for uterine smooth muscle tumor of uncertain malignant potential: A case report and review of the literature.子宫平滑肌肿瘤恶性潜能不确定行肌瘤切除术后成功妊娠:一例报告并文献复习
Gynecol Oncol Rep. 2015 Aug 7;15:1-3. doi: 10.1016/j.gore.2015.07.005. eCollection 2016 Jan.